Whistleblower’s decades long fight to save patients from dangerous research

BiographyNancy Olivieri, an internist and haematologist, graduated from McMaster University Medical School in Ontario and holds a masters degree in medical ethics and law from King’s College London and a masters of fine art in creative non-fiction from the University of King’s College, Halifax, Canada. She is a senior scientist at Toronto General Hospital and professor of paediatrics, medicine, and public health sciences at the University of Toronto.In 1982, while still a research fellow at Toronto’s Hospital for Sick Children, Nancy Olivieri began working with children with the common inherited blood disorder thalassaemia major, who are at risk of toxic iron overload as a result of monthly transfusions. In 1988 and 1992 Olivieri launched two clinical trials supported by the Medical Research Council of Canada to evaluate the effectiveness of a new drug, deferiprone, in removing body iron. Early results were promising,1 but during extended exposure to the drug concerns…
Read Original Article: Whistleblower’s decades long fight to save patients from dangerous research »